Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial SarcomaTetsuya Sekita(Keio University), Mari MasudaCancersMay 16, 202010.3390/cancers12051258Cited by 23SaveCiteExport RISWatch citationsRelated PapersTNIK inhibition abrogates colorectal cancer stemness|Nature Communications|2016|165